Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognostic value of these biomarkers in hepatocellular carcinoma

We aimed to investigate the associations between components of the phosphatase and tensin homolog deleted on chromosome 10/protein kinase B/mammalian target of rapamycin (PTEN/AKT/mTOR) pathway and liver cancer stem cell (LCSC) markers, including CD133, CD90, CD44, and epithelial cell adhesion molecule (EpCAM), and to further evaluate the predictive values of these biomarkers for recurrence and survival in hepatocellular carcinoma (HCC).

[1]  Z. Han,et al.  Inhibition of Notch Signaling Promotes the Adipogenic Differentiation of Mesenchymal Stem Cells Through Autophagy Activation and PTEN-PI3K/AKT/mTOR Pathway , 2015, Cellular Physiology and Biochemistry.

[2]  P. Nangia-Makker,et al.  miR-21 and miR-145 cooperation in regulation of colon cancer stem cells , 2015, Molecular Cancer.

[3]  P. Nangia-Makker,et al.  miR-21 and miR-145 cooperation in regulation of colon cancer stem cells , 2015, Molecular Cancer.

[4]  Z. Qiu,et al.  The protein phosphatase activity of PTEN is essential for regulating neural stem cell differentiation , 2015, Molecular Brain.

[5]  Pu Xia,et al.  PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. , 2015, American journal of cancer research.

[6]  Xing Wang,et al.  The role of COX-2 in mediating the effect of PTEN on BMP9 induced osteogenic differentiation in mouse embryonic fibroblasts. , 2014, Biomaterials.

[7]  P. Gao,et al.  Human Fibroblast Reprogramming to Pluripotent Stem Cells Regulated by the miR19a/b-PTEN Axis , 2014, PloS one.

[8]  T. Lawrence,et al.  Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice. , 2014, Gastroenterology.

[9]  Huashun Li,et al.  PTEN regulation of the proliferation and differentiation of auditory progenitors through the PTEN/PI3K/Akt-signaling pathway in mice , 2014, Neuroreport.

[10]  K. Kissa,et al.  Pivotal role of Pten in the balance between proliferation and differentiation of hematopoietic stem cells in zebrafish. , 2014, Blood.

[11]  M. Wicha.  Targeting self-renewal, an Achilles' heel of cancer stem cells , 2014, Nature Medicine.

[12]  A. Krešo,et al.  Self-renewal as a therapeutic target in human colorectal cancer , 2013, Nature Medicine.

[13]  K. Hui,et al.  MicroRNA‐216a/217‐induced epithelial‐mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer , 2013, Hepatology.

[14]  John Woulfe,et al.  PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1 , 2013, Oncotarget.

[15]  W. Duan,et al.  Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells. , 2013, Stem cells and development.

[16]  C. Heeschen,et al.  Standing out from the crowd: cancer stem cells in hepatocellular carcinoma. , 2013, Cancer cell.

[17]  X. Wang,et al.  Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma , 2013, Hepatology.

[18]  W. Guo,et al.  Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection , 2013, Hepatology.

[19]  Yi Lv,et al.  PTEN enhances the sensitivity of human hepatocellular carcinoma cells to sorafenib. , 2012, Oncology research.

[20]  H. Johnsen,et al.  Cancer stem cell definitions and terminology: the devil is in the details , 2012, Nature Reviews Cancer.

[21]  Peter Dirks,et al.  Cancer stem cells: an evolving concept , 2012, Nature Reviews Cancer.

[22]  L. Tran,et al.  Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. , 2011, Cancer cell.

[23]  Yushui Ma,et al.  The power and the promise of liver cancer stem cell markers. , 2011, Stem cells and development.

[24]  Zhaokai Wang,et al.  PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells , 2011, Molecular and Cellular Biochemistry.

[25]  I. Ng,et al.  Lupeol targets liver tumor‐initiating cells through phosphatase and tensin homolog modulation , 2011, Hepatology.

[26]  Rong Wang,et al.  Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.

[27]  I. Ng,et al.  miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. , 2010, Cell stem cell.

[28]  C. Heeschen,et al.  Pancreatic cancer stem cells – update and future perspectives , 2010, Molecular oncology.

[29]  S. Thorgeirsson,et al.  Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. , 2010, Journal of hepatology.

[30]  Xuan Liang,et al.  PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells. , 2010, Carcinogenesis.

[31]  N. Hayashi,et al.  Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma. , 2010, Journal of hepatology.

[32]  S. Qiu,et al.  High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma , 2010, Gut.

[33]  C. Cavard,et al.  EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. , 2010, Journal of hepatology.

[34]  M. Büchler,et al.  Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter. , 2009, Cancer letters.

[35]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[36]  Q. Wang,et al.  Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP‐9 , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[37]  M. Wicha,et al.  Cancer stem cells: a step toward the cure. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Jin Woo Kim,et al.  EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. , 2008, Cancer research.

[39]  S. Fan,et al.  Significance of CD90+ cancer stem cells in human liver cancer. , 2008, Cancer cell.

[40]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[41]  I. Ng,et al.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.

[42]  S. Badve,et al.  Breast-cancer stem cells-beyond semantics. , 2012, The Lancet. Oncology.

[43]  L. Ricci-Vitiani,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[44]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.